FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
TAGRX
Price
$70.01
Change
+$0.58 (+0.84%)
Updated
Aug 21 closing price
Net Assets
6.1B
Interact to see
Advertisement

FXAIX vs TAGRX

FXAIX vs TAGRX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. TAGRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and TAGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. TAGRX (6.1B). FXAIX pays higher dividends than TAGRX: FXAIX (1.06) vs TAGRX (0.22). FXAIX was incepted earlier than TAGRX: FXAIX (15 years) vs TAGRX (42 years). TAGRX (1.02) is less costly to investors than FXAIX (0.01). TAGRX is a more actively managed with annual turnover of: 49.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than TAGRX: FXAIX (0) vs TAGRX (1000). FXAIX annual gain was more profitable for investors over the last year : 21.35 vs. TAGRX (1.66). FXAIX return over 5 years is better than : 84.67 vs. TAGRX (-4.17).
FXAIXTAGRXFXAIX / TAGRX
Total Expense Ratio0.011.011%
Annual Report Gross Expense Ratio0.011.021%
Fund Existence15 years42 years-
Gain YTD12.4376.739185%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets833B6.1B13,658%
Annual Yield % from dividends1.060.22473%
Returns for 1 year21.351.661,289%
Returns for 3 years81.1518.50439%
Returns for 5 years84.67-4.17-2,029%
Returns for 10 years286.5763.04455%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX55.570.84
+1.53%
Rydex Biotechnology C
RSLBX70.040.57
+0.82%
American Funds SMALLCAP World R-2
RYPNX20.180.16
+0.80%
Royce Small-Cap Opportunity Invmt
VSORX54.480.35
+0.65%
Victory Sycamore Small Company Opp R6
BLNIX15.060.05
+0.33%
Meeder Balanced Institutional